MENU
+Compare
RLYB
Stock ticker: NASDAQ
AS OF
Jan 17, 04:59 PM (EDT)
Price
$0.87
Change
-$0.02 (-2.25%)
Capitalization
36.92M

RLYB Rallybio Corp Forecast, Technical & Fundamental Analysis

Industry Biotechnology
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RLYB with price predictions
Jan 14, 2025

RLYB sees MACD Histogram crosses below signal line

RLYB saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 14, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 31 instances where the indicator turned negative. In of the 31 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RLYB as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RLYB moved below its 50-day moving average on January 08, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RLYB crossed bearishly below the 50-day moving average on December 23, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RLYB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RLYB's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RLYB advanced for three days, in of 204 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.521) is normal, around the industry mean (15.339). P/E Ratio (0.000) is within average values for comparable stocks, (87.552). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.851). RLYB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (63.291) is also within normal values, averaging (263.778).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RLYB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RLYB is expected to report earnings to rise 15.38% to -30 cents per share on March 18

Rallybio Corp RLYB Stock Earnings Reports
Q4'24
Est.
$-0.30
Q3'24
Beat
by $0.09
Q2'24
Missed
by $0.30
Q1'24
Est.
$-0.47
Q4'23
Missed
by $0.03
The last earnings report on November 07 showed earnings per share of -25 cents, beating the estimate of -34 cents. With 95.43K shares outstanding, the current market capitalization sits at 36.92M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

RLYB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with ALT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
-1.12%
ALT - RLYB
36%
Loosely correlated
+1.98%
VERU - RLYB
35%
Loosely correlated
+13.94%
GBIO - RLYB
33%
Loosely correlated
+6.57%
CDXS - RLYB
32%
Poorly correlated
+1.03%
FHTX - RLYB
32%
Poorly correlated
-3.45%
More